InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Sachs David C., Chief Financial Officer. Officer active across 1 company, notably ImmunityBio, Inc.. Cumulatively, 11 reports have been logged. Activity tracked since 9 September 2021. The latest transaction was filed on 22 February 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations
David C. Sachs is Chief Financial Officer at ImmunityBio, Inc. He has 11 filings in total, and the sampled recent filings run from 2021-09-13 to 2026-02-24, with the dominant transaction nature shown as option exercise.